Exploring the impact of glycemic control on renal, hepatic, and lipid biomarkers in diabetic patients: a retrospective laboratory analysis from 2019 to 2022
This retrospective laboratory analysis from 2019 to 2022 demonstrates that poor glycemic control in diabetic patients is significantly associated with concurrent abnormalities in renal, hepatic, and lipid biomarkers, underscoring the clinical necessity of interpreting HbA1c alongside these organ-specific markers to better detect complications and guide personalized care.